RVMD – Revolution Medicines, Inc.
RVMD — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
6.91
Margin Of Safety %
Put/Call OI Ratio
1.25
EPS Next Q Diff
-4.68
EPS Last/This Y
-2.01
EPS This/Next Y
2.5
Price
145.76
Target Price
181.3
Analyst Recom
1
Performance Q
51.82
Upside
-269.8%
Beta
1.4
Ticker: RVMD
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-04-13 | RVMD | 134.55 | 1.63 | 1.60 | 129729 |
| 2026-04-14 | RVMD | 147.01 | 1.50 | 0.22 | 142303 |
| 2026-04-15 | RVMD | 152.48 | 1.40 | 0.38 | 153341 |
| 2026-04-17 | RVMD | 148.62 | 1.29 | 0.72 | 168983 |
| 2026-04-20 | RVMD | 146.29 | 1.38 | 0.67 | 121824 |
| 2026-04-21 | RVMD | 148.86 | 1.36 | 0.84 | 125857 |
| 2026-04-23 | RVMD | 134.29 | 1.38 | 1.37 | 128725 |
| 2026-04-24 | RVMD | 135.32 | 1.41 | 1.87 | 131001 |
| 2026-04-27 | RVMD | 131.45 | 1.40 | 0.42 | 131628 |
| 2026-04-28 | RVMD | 144.75 | 1.36 | 0.92 | 137296 |
| 2026-04-29 | RVMD | 140.55 | 1.36 | 0.20 | 141421 |
| 2026-04-30 | RVMD | 144.09 | 1.35 | 0.40 | 141602 |
| 2026-05-01 | RVMD | 139.51 | 1.33 | 0.10 | 143512 |
| 2026-05-04 | RVMD | 147.78 | 1.27 | 0.48 | 146233 |
| 2026-05-05 | RVMD | 147.26 | 1.28 | 0.21 | 147107 |
| 2026-05-06 | RVMD | 150.91 | 1.26 | 0.08 | 148498 |
| 2026-05-07 | RVMD | 143.11 | 1.25 | 0.32 | 149272 |
| 2026-05-08 | RVMD | 141.77 | 1.25 | 0.13 | 149840 |
| 2026-05-11 | RVMD | 144.12 | 1.25 | 0.45 | 149845 |
| 2026-05-12 | RVMD | 145.81 | 1.25 | 0.04 | 150190 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-04-13 | RVMD | 136.31 | -58.8 | -1297.3 | -7.61 |
| 2026-04-14 | RVMD | 147.04 | -58.8 | -1500.6 | -7.61 |
| 2026-04-15 | RVMD | 152.58 | -58.8 | -1605.7 | -7.61 |
| 2026-04-16 | RVMD | 149.17 | -58.8 | -1541.1 | -7.61 |
| 2026-04-17 | RVMD | 148.62 | -61.6 | -1680.8 | -7.73 |
| 2026-04-20 | RVMD | 146.17 | -61.6 | -1631.8 | -7.73 |
| 2026-04-21 | RVMD | 148.85 | -61.6 | -1724.5 | -7.72 |
| 2026-04-22 | RVMD | 141.48 | -61.6 | -1575.4 | -7.72 |
| 2026-04-23 | RVMD | 134.30 | -61.9 | -1430.2 | -7.61 |
| 2026-04-24 | RVMD | 135.30 | -61.9 | -1450.4 | -7.61 |
| 2026-04-27 | RVMD | 131.79 | -62.6 | -1379.4 | -7.48 |
| 2026-04-28 | RVMD | 144.82 | -62.6 | -1643.0 | -7.48 |
| 2026-04-30 | RVMD | 144.21 | -62.6 | -1645.8 | -7.48 |
| 2026-05-01 | RVMD | 139.60 | -62.6 | -1552.2 | -7.48 |
| 2026-05-04 | RVMD | 147.80 | -62.6 | -1718.9 | -7.48 |
| 2026-05-05 | RVMD | 147.22 | -62.6 | -1707.0 | -7.48 |
| 2026-05-06 | RVMD | 150.82 | -62.6 | -1790.2 | -7.48 |
| 2026-05-07 | RVMD | 142.44 | -62.6 | -1609.9 | -7.48 |
| 2026-05-08 | RVMD | 141.85 | -62.6 | - | -7.48 |
| 2026-05-11 | RVMD | 144.18 | -58.2 | - | -7.89 |
| 2026-05-12 | RVMD | 145.76 | -52.4 | - | -7.96 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-04-13 | RVMD | -1.57 | 2.67 | 8.95 |
| 2026-04-14 | RVMD | -1.57 | 2.67 | 8.95 |
| 2026-04-15 | RVMD | -1.57 | 2.67 | 8.95 |
| 2026-04-16 | RVMD | -1.47 | 2.67 | 8.95 |
| 2026-04-17 | RVMD | -1.47 | 2.67 | 8.95 |
| 2026-04-20 | RVMD | -1.82 | 2.53 | 8.49 |
| 2026-04-21 | RVMD | -1.82 | 2.53 | 8.49 |
| 2026-04-22 | RVMD | -1.82 | 2.53 | 8.49 |
| 2026-04-23 | RVMD | -1.82 | 2.53 | 8.49 |
| 2026-04-24 | RVMD | -1.82 | 2.53 | 8.49 |
| 2026-04-27 | RVMD | -1.82 | 1.46 | 7.36 |
| 2026-04-28 | RVMD | -1.85 | 1.46 | 7.36 |
| 2026-04-29 | RVMD | -1.86 | 1.46 | 7.36 |
| 2026-04-30 | RVMD | -1.86 | 1.46 | 7.36 |
| 2026-05-01 | RVMD | -1.83 | 1.46 | 7.23 |
| 2026-05-04 | RVMD | -1.83 | 0.64 | 7.23 |
| 2026-05-05 | RVMD | -1.83 | 0.64 | 7.23 |
| 2026-05-06 | RVMD | -1.83 | 0.64 | 7.23 |
| 2026-05-07 | RVMD | -1.83 | 0.64 | 7.23 |
| 2026-05-08 | RVMD | -1.83 | 0.64 | 7.23 |
| 2026-05-11 | RVMD | -1.83 | 0.11 | 7.23 |
| 2026-05-12 | RVMD | -1.83 | 0.11 | 6.91 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
2.72
Avg. EPS Est. Current Quarter
-2
Avg. EPS Est. Next Quarter
-1.96
Insider Transactions
-1.83
Institutional Transactions
0.11
Beta
1.4
Average Sales Estimate Current Quarter
18
Average Sales Estimate Next Quarter
7
Fair Value
Quality Score
4
Growth Score
23
Sentiment Score
77
Actual DrawDown %
6.4
Max Drawdown 5-Year %
-58.2
Target Price
181.3
P/E
Forward P/E
PEG
P/S
P/B
19.45
P/Free Cash Flow
EPS
-7.07
Average EPS Est. Cur. Y
-7.96
EPS Next Y. (Est.)
-5.46
Target Price Estimates Raised
5
Target Price Estimates Lowered
1
Profit Margin
Relative Volume
0.48
Return on Equity vs Sector %
-118.3
Return on Equity vs Industry %
-102.8
EPS 1 7Days Diff
-0.5
EPS 1 30Days Diff
-0.35
EBIT Estimation
◆
RVMD
Healthcare
$145.72
Swing / Pullback
Buy the dip on strong trends
WATCH
RSI
60.1
Range 1M
62.9%
Sup Dist
2.6%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-33%
EPS NY
30%
52W%
91.2%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+24.4% upside
Upside
+24.4%
Quality
4
Revolution Medicines, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 883
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
RVMD
Latest News
—
Caricamento notizie per RVMD…
stock quote shares RVMD – Revolution Medicines, Inc. Stock Price stock today
news today RVMD – Revolution Medicines, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RVMD – Revolution Medicines, Inc. yahoo finance google finance
stock history RVMD – Revolution Medicines, Inc. invest stock market
stock prices RVMD premarket after hours
ticker RVMD fair value insiders trading